Modernise Adverse Event Intake Without Replacing Your Safety Stack


AI-assisted adverse event intake for global pharmacovigilance - built on Qinecsa’s proven Reportum platform, with human review and regulatory-grade governance at its core.

Expert Perspective:

Building AI That Delivers Real Value


Many life sciences organisations are exploring AI, but the real challenge isn't launching pilots—it's creating the right foundations for success.

In this short commentary, Beena Wood shares her perspective on why data quality, governance and realistic expectations are critical to achieving meaningful outcomes from AI in pharmacovigilance.

The challenge

Global pharmacovigilance teams manage high-volume, multilingual adverse event intake across affiliates, patient support programmes and multiple reporting channels. Up to 80% of reports still arrive as emails, PDFs and paper documents - driving cost, delay and compliance risk.


The solution

Reportum Intake AI adds a scalable, intelligent intake layer above your existing safety systems. It automatically extracts, structures, translates and routes adverse event reports into validated workflows, while preserving human oversight and full auditability at every step.


What you get

  • Up to 60% reduction in manual case processing effort
  • Faster case availability and earlier signal visibility
  • Multilingual extraction, translation and structured digital follow-up
  • Human review and regulatory-grade governance built in
  • Works with Argus, ArisGlobal and Veeva Safety - no platform replacement

Why Qinecsa?


Reportum is already trusted by leading global pharmaceutical organisations. Reportum Intake AI extends that proven foundation with AI-assisted automation designed for regulated environments.

See it on your own reports

Watch Reportum Intake AI process a live adverse event report and model the impact on your intake operations.


Book a Demo

Qinecsa Solutions  | All rights reserved

Thank You!

Thank you ! Your form has been submitted